BRIGHTMEDS GLP-1: A DEEP LOOK INTO THIS INNOVATIVE THERAPY

GLP-1 receptor agonists , particularly those like BrightMeds, are rapidly gaining prominence in the management of type 2 diabetes and are also explored for obesity . These novel drugs work by mimicking the body's natural incretin release, stimulating glucose-dependent insulin secretion and curbin